Evidence map›Paper›PMID 38644881›Full record

ArticleHeliyon2024

The potential molecular mechanism underlying gypenoside amelioration of atherosclerosis in ApoE

Xing Ju, Yufeng Liu, Ying Wang, Guoyuan Sui, Yixin Ma, Huimin Cao, Yuan Cao, Jin Wu, Ying Du, Xue Leng and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Xing JuTCM Innovation Engineering Technology Center, Liaoning University of Traditional Chinese Medicine, Shenyang, 110847, China.
Yufeng LiuCenter for Medical Research on Innovation and Translation, Guangzhou First People' S Hospital, Guangzhou, 510180, China.
Ying WangTCM Innovation Engineering Technology Center, Liaoning University of Traditional Chinese Medicine, Shenyang, 110847, China.
Guoyuan SuiSchool of Integrated Traditional Chinese and Western Medicine, Liaoning University of Traditional Chinese Medicine, Shenyang, 110847, China.
Yixin MaTCM Innovation Engineering Technology Center, Liaoning University of Traditional Chinese Medicine, Shenyang, 110847, China.
Huimin CaoTCM Innovation Engineering Technology Center, Liaoning University of Traditional Chinese Medicine, Shenyang, 110847, China.
Yuan CaoTCM Innovation Engineering Technology Center, Liaoning University of Traditional Chinese Medicine, Shenyang, 110847, China.
Jin WuTCM Innovation Engineering Technology Center, Liaoning University of Traditional Chinese Medicine, Shenyang, 110847, China.
Ying DuTCM Innovation Engineering Technology Center, Liaoning University of Traditional Chinese Medicine, Shenyang, 110847, China.
Xue LengSchool of Integrated Traditional Chinese and Western Medicine, Liaoning University of Traditional Chinese Medicine, Shenyang, 110847, China.
Lianqun JiaKey Laboratory of Ministry of Education for TCM Viscera-State Theory and Applications, Liaoning University of Traditional Chinese Medicine, Shenyang, 110847, China.
Guanlin YangKey Laboratory of Ministry of Education for TCM Viscera-State Theory and Applications, Liaoning University of Traditional Chinese Medicine, Shenyang, 110847, China.
Liaoning University of Traditional Chinese Medicine · CNGuangzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gypenosides (Gyp) are bioactive components of

Indexed as

ArteriosclerosisGypenosidesMetabolomicsTranscriptomics

Identifiers

PMID38644881
PMCPMC11031777
OpenAlexW4394795448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.